New York, USA - November 14, 2024 - In recent years, antisense oligonucleotides (ASO) therapy has emerged as a promising approach in the treatment of various genetic disorders. ASOs are short, synthetic strands of nucleic acids designed to specifically bind to messenger RNA (mRNA), resulting in the modulation of gene expression, and providing new avenues for therapeutic interventions, particularly in the realm of rare diseases and neurodegenerative disorders. In light of this ongoing advancement, Creative Biolabs is proud to announce the launch of its comprehensive solutions tailored for antisense oligonucleotide therapy research.
At a gene therapy-related exhibition, scientists from Creative Biolabs introduced products and services related to antisense oligonucleotides, with a particular emphasis on antisense oligonucleotide screening.
"Efficient ASO screening enables researchers to identify the most effective oligonucleotide sequences for their target genes. Our high-throughput workflow can simultaneously test thousands of ASOs in vitro and finally select expected candidate ASOs." said a scientist at Creative Biolabs. "The synthesis of high-quality antisense oligonucleotides is another crucial step."
Creative Biolabs offers a suite of antisense oligonucleotide synthesis and screening services for a variety of purposes.
"We enabled the facilities equipped with high-end equipment which can produce ASOs of high purity and specificity. There are options for our clients such as the provision of phosphorothioate backbones for their ASOs and other conjugations for better stability and delivery," said the scientist.
Throughout the entire development process, the company adheres to strict quality control measures, from the design phase to the purification stage. Their team utilizes advanced analytical techniques such as HPLC, mass spectrometry, and sequencing to ensure the identity and integrity of each oligonucleotide.
"We found a scientist from Japan recently explored the use of ASOs to reduce the expression of aSyn and improve symptoms in a mouse model of Parkinson's disease. This is a good news for us. The field is rapidly evolving, and our company is committed to staying at the forefront of this research and continuously improving our ASO synthesis services to meet these emerging needs," added the scientist.
Learn more about antisense oligonucleotide solutions and related products, please visit https://www.creative-biolabs.com/gene-therapy.
About Creative Biolabs
Creative Biolabs is at the forefront of addressing the demands of specialized solutions for ASOs, providing researchers with the tools required to advance their work in antisense oligonucleotide therapy. Aiming at creativity, high standards of quality, and support, Creative Biolabs is giving more power to scientists in their quest to use gene therapy to discover new elements.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy
